Glenn Wortmann

ORCID: 0000-0002-7801-8871
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Research on Leishmaniasis Studies
  • Antibiotic Resistance in Bacteria
  • HIV/AIDS Research and Interventions
  • Trypanosoma species research and implications
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS drug development and treatment
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacillus and Francisella bacterial research
  • Vibrio bacteria research studies
  • Long-Term Effects of COVID-19
  • HIV Research and Treatment
  • Urinary Tract Infections Management
  • Antibiotic Use and Resistance
  • Trauma and Emergency Care Studies
  • Viral Infections and Vectors
  • Disaster Response and Management
  • Clostridium difficile and Clostridium perfringens research
  • Hepatitis B Virus Studies
  • HIV-related health complications and treatments
  • Vector-borne infectious diseases
  • Surgical site infection prevention
  • HIV, Drug Use, Sexual Risk
  • Antifungal resistance and susceptibility
  • Mosquito-borne diseases and control

MedStar Washington Hospital Center
2016-2025

Association Clinique et Thérapeutique Infantile du Val de Marne
2023-2024

Walter Reed Army Institute of Research
2004-2024

Health and Education Research Management and Epidemiologic Services (United States)
2023

MedStar Georgetown University Hospital
2019-2023

Georgetown University
2015-2023

MedStar Health
2019-2022

Washington Hospital
2020-2021

University of Calgary
2018

Foothills Medical Centre
2018

The incidence of acute renal failure, defined by the risk, injury, or failure criteria RIFLE (risk, loss, and end-stage kidney disease), in 66 patients who received colistimethate sodium was 45%, 21% stopped therapy because nephrotoxicity. should be used future to allow for comparison nephrotoxicity among studies.

10.1086/599225 article EN Clinical Infectious Diseases 2009-05-13

The poor outcome of the coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, is associated with systemic hyperinflammatory response and immunopathology. Although inflammasome oxidative stress have independently been implicated in COVID-19, it poorly understood whether these two pathways cooperatively contribute to disease severity. Herein, we found an enrichment CD14highCD16- monocytes displaying activation evidenced caspase-1/ASC-speck formation severe COVID-19 patients when compared...

10.3389/fimmu.2021.799558 article EN cc-by Frontiers in Immunology 2022-01-14
Jane A. O’Halloran Emily R. Ko Kevin J. Anstrom Eyal Kedar Matthew W. McCarthy and 95 more Reynold A. Panettieri Martin Maillo Patricia Segura Nunez Anne M. Lachiewicz Cynthia Gonzalez P. Brian Smith Sabina Mendivil-Tuchia de Tai Akram Khan Alfredo J Mena Lora Matthias Salathé Gerardo Capo Daniel González Thomas F. Patterson Christopher Palma Horacio Ariza Maria Patelli Juliani Souza Lima John Blamoun Esteban C. Nannini Eduardo Sprinz Analía Mykietiuk Radica Z. Alicic Adriana M. Rauseo Cameron R. Wolfe Britta Witting Jennifer Wang Luis Parra-Rodriguez Tatyana Der Kate Willsey Jun Wen A Silverstein Sean M. O’Brien Hussein R. Al‐Khalidi Michael A. Maldonado Richard Melsheimer William Ferguson Steven E. McNulty Pearl Zakroysky Susan Halabi Daniel K. Benjamin Sandra Butler Jane C. Atkinson Stacey J. Adam Soju Chang Lisa M. LaVange Michael A. Proschan Samuel A. Bozzette William G. Powderly Mihir Patel Arun J. Sanyal Jason Green Huimin Wu Benjamin P. Linas Philip Grant Vivek Iyer Otto O. Yang Bindu Balani Sam Parnia Ryan K Dare Caryn G. Morse Estelle S. Harris Glenn Wortmann Nicholas S. Hill Shama Patel Julia Garcia‐Diaz Suman Thapamager Megan Devine Christine M. Bojanowski Barry Meisenberg Gailen D. Marshall Dima Dandachi Arick P. Sabin Anthony Breemo Suman Sinha Christopher H. Goss Rebecca Reece Arlette Aouad Seth Glassman Peter E. Morris Bela Patel Fatimah Bello Juliana Cardozo Fernandes Oscar Carbajal L Ravera Mozar Castro Miguel Villegas-Chiroque Fernando Riera A. Casado Camacho Claudio Stadnik Jorge Gave Rodrigo Biondi Ronal Gamarra Velarde José Cerbino Neto J. Ditondo Marcelo Losso M. Dolz

Importance Immune dysregulation contributes to poorer outcomes in COVID-19. Objective To investigate whether abatacept, cenicriviroc, or infliximab provides benefit when added standard care for COVID-19 pneumonia. Design, Setting, and Participants Randomized, double-masked, placebo-controlled clinical trial using a master protocol immunomodulators treatment of participants hospitalized with The results 3 substudies are reported from 95 hospitals at 85 research sites the US Latin America....

10.1001/jama.2023.11043 article EN JAMA 2023-07-10

The malaria sporozoite vaccine candidate RTS,S, formulated with an oil-in-water emulsion plus the immunostimulants monophosphoryl lipid A and saponin derivative QS21 (vaccine 3), recently showed superior efficacy over two other experimental formulations. Immunized volunteers were followed to determine duration of protective immune responses. Antibody levels decreased between one-third one-half peak values 6 months after last dose vaccine. T cell proliferation interferon-γ production in vitro...

10.1086/515657 article EN The Journal of Infectious Diseases 1998-10-01

Major advances in combat casualty care have led to increased survival of patients with complex extremity trauma. Invasive fungal wound infections (IFIs) are an uncommon, but increasingly recognized, complication following trauma that require greater understanding risk factors and clinical findings reduce morbidity.The patient population includes US military personnel injured during from June 2009 through December 2010. Case definition required necrosis on successive debridements IFI evidence...

10.1093/cid/cis749 article EN Clinical Infectious Diseases 2012-10-05

Background. Colistin resistance is of concern since it increasingly needed to treat infections caused by bacteria resistant all other antibiotics and has been associated with poorer outcomes. Longitudinal data from in vivo series are sparse. Methods. Under a quality-improvement directive intensify infection-control measures, extremely drug-resistant (XDR) undergo phenotypic molecular analysis. Results. Twenty-eight XDR Acinetobacter baumannii isolates were longitudinally recovered during...

10.1093/infdis/jit293 article EN The Journal of Infectious Diseases 2013-06-28

Treatment options for cutaneous leishmaniasis in the United States are problematic because available products either investigational, toxic, and/or of questionable effectiveness. A retrospective review patients receiving liposomal amphotericin B through Walter Reed Army Medical Center treatment during 2007-2009 was conducted. Twenty who acquired disease five countries and with different strains Leishmania were treated, whom 19 received a full course treatment. Sixteen (84%) experienced cure...

10.4269/ajtmh.2010.10-0171 article EN American Journal of Tropical Medicine and Hygiene 2010-10-29

Background. Understanding the impact of hepatitis B virus (HBV) in human immunodeficiency (HIV) coinfection has been limited by heterogeneity HIV disease. We evaluated HBV and HIV-related disease progression a cohort seroconverters.

10.1093/infdis/jir720 article EN The Journal of Infectious Diseases 2011-12-05

Uncomplicated Delivery in a Patient with Covid-19 The peripartum care of woman at 39 weeks gestation is described. and the neonate were discharged home on hospital day ...

10.1056/nejmc2007605 article EN New England Journal of Medicine 2020-04-01

We evaluated saliva (SAL) specimens for SARS-CoV-2 reverse transcriptase PCR (RT-PCR) testing by comparison of 459 prospectively paired nasopharyngeal (NP) or midturbinate (MT) swabs from 449 individuals with the aim using asymptomatic screening. Samples were collected in a drive-through car line symptomatic ( n = 380) and emergency department (ED) 69).

10.1128/jcm.02486-20 article EN Journal of Clinical Microbiology 2020-12-02
Minggui Wang Lizhao Ge Liang Chen Lauren Komarow Blake Hanson and 95 more Jinnethe Reyes Eric Cober Thamer H. Alenazi Zhiyong Zong Qing Xie Zhengyin Liu Lanjuan Li Yunsong Yu Hainv Gao Souha S. Kanj Jairo Figueroa Erica Herc Ezequiel Córdova Gregory Weston Paul Anantharajah Tambyah Julia Garcia‐Diaz Keith S. Kaye Sorabh Dhar José M. Munita Robert A. Salata Samuel Vilchez Martín E. Stryjewski María Virginia Villegas Alina Iovleva Scott Evans Keri Baum Carol Hill Barry N. Kreiswirth Robin Patel David L. Paterson César A. Arias Robert A. Bonomo Henry F. Chambers Vance G. Fowler Michael J. Satlin David van Duin Yohei Doi Souha S. Kanj Fujie Zhang Judith J. Lok Robert A. Salata Martín E. Stryjewski Valentina Di Castelnuovo Jose Millan Oñate Gutierrez Eric Cober Susan Richter Deverick J. Anderson Beth Evans Carol Hill H. R. Cross Keri Baum Rebekka M. Arias Vance G. Fowler Karen Ordóñez Jesse T. Jacob Linghua Li Barry N Kreiswirth Claudia Manca Liang Chen Samit Desai Erica Herc Ezequiel Córdova María Luisa Rioseco Samuel Vilchez Marisa Sánchez Sandra Valderrama Jairo Figueroa César A. Arias An Q Dinh Diane Panesso Kirsten Rydell Truc T. Tran Fupin Hu Jiachun Su Jianping Jiang Minggui Wang Xiaogang Xu Yang Yang José M. Munita María Spencer Thamer H. Alenazi Robert A. Bonomo Steven H. Marshall Susan D. Rudin W. Charles Huskins Kerry Greenwood-Quaintance Robin Patel Suzannah M. Schmidt-Malan Sara Revolinski Glenn Wortmann Robert C. Kalayjian Gregory Weston Belinda Ostrowsky Gopi Patel Daniel Eiras

Carbapenem-resistant Acinetobacter baumannii (CRAb) is 1 of the most problematic antimicrobial-resistant bacteria. We sought to elucidate international epidemiology and clinical impact CRAb. In a prospective observational cohort study, 842 hospitalized patients with CRAb culture were enrolled at 46 hospitals in five global regions between 2017 2019. The primary outcome was all-cause mortality 30 days from index culture. strains underwent whole-genome analysis. Of cases, 536 (64%) represented...

10.1093/cid/ciad556 article EN Clinical Infectious Diseases 2023-09-20

Background: War-trauma, especially due to blast injury, can be associated with long bone fracture. Immediate external fixation of fractures, followed by internal when the patient is medically stabilized (damage control orthopedics [DCO]), U.S. Army policy for war-related fractures. Data on infectious outcomes DCO used war-trauma fractures are scant. Methods: A retrospective review patients from 2003 2007 femoral or tibial treated was conducted. Fisher's Exact and Mann-Whitney tests were...

10.1097/ta.0b013e3181af6aa6 article EN Journal of Trauma and Acute Care Surgery 2009-10-01

To determine the anatomic sites and natural history of colonization with gram-negative multidrug-resistant organisms (MDROs).Prospective, longitudinal cohort study.Walter Reed Army Medical Center, a 236-bed tertiary care center in Washington, DC.Deployed subjects (ie, inpatients medically evacuated from Iraq or Afghanistan) nondeployed admitted to same hospital.Consenting patients had 6 cultured every 3 days for 2 weeks then weekly. Gram-negative resistant more classes antibiotics were...

10.1086/651304 article EN Infection Control and Hospital Epidemiology 2010-02-22

Background Cutaneous Leishmania major has affected many travelers including military personnel in Iraq and Afghanistan. Optimal treatment for this localized infection not been defined, but interestingly the parasite is thermosensitive. Methodology/Principal Findings Participants with parasitologically confirmed L. were randomized to receive intravenous sodium stibogluconate (SSG) 20mg/kg/day ten doses or ThermoMed (TM) device heat (applied at 50°C 30 seconds) one session. Those facial...

10.1371/journal.pntd.0000628 article EN cc-by PLoS neglected tropical diseases 2010-03-08

The efficacy and toxicity of sodium stibogluconate (SSG) at a dosage 20 mg/(kg.d) for either days (for cutaneous disease) or 28 visceral, mucosal, viscerotropic in the treatment leishmaniasis is reported. Ninety-six U.S. Department Defense health care beneficiaries with parasitologically confirmed were prospectively followed 1 year. One patient was infected human immunodeficiency virus; otherwise, comorbidity absent. Clinical cure occurred 91% 83 cases disease 93% 13 visceral/viscerotropic...

10.1086/515027 article EN Clinical Infectious Diseases 1998-12-01

A fluorescent DNA probe (LEIS.P1) specific for a conserved region of the small-subunit ribosomal RNA gene Leishmania and pair flanking primers (LEIS.U1 LEIS.L1) were designed use in fluorogenic polymerase chain reaction. Optimal assay conditions with zero background established to detect low levels from clinical samples. By this assay, we amplified 27 strains cultured (both Old New World strains) selectively 12 paraffin-embedded human biopsy samples 3 fresh skin specimens. For tissue...

10.4269/ajtmh.2001.65.583 article EN American Journal of Tropical Medicine and Hygiene 2001-11-01

A real-time PCR assay for the detection of four Leishmania complexes (L. Viannia, L. mexicana, donovani/infantum, and major) was developed evaluated. The to detect glucosephosphate isomerase gene capitalizes on DNA sequence variability within that complex identification. Primer/probe sets were created tested against a panel 21 known negative controls extracted from cultured promastigotes or tissue biopsies patients with cutaneous leishmaniasis. highly specific, as no amplification products...

10.4269/ajtmh.2005.73.999 article EN American Journal of Tropical Medicine and Hygiene 2005-12-01

The recommended treatment for cutaneous leishmaniasis is pentavalent antimony at a dosage of 20 mg/kg/day days. Some studies conducted in locales which Leishmania endemic have suggested that shorter courses may be as efficacious. We randomized, double-blind, placebo-controlled study 10 versus days sodium stibogluconate (SSG) United States military personnel who contracted while serving overseas; 19 patients received SSG (and placebo days), and Cure rates were 100% (19 patients) the 10-day...

10.1086/341406 article EN Clinical Infectious Diseases 2002-08-01

Management of combat-related trauma is derived from skills and data collected in past conflicts civilian trauma, information experience obtained during ongoing conflicts. The best methods to prevent infections associated with injuries observed military combat are not fully established. Current these types primarily controlled trials elective surgery as well retrospective studies interventions. following guidelines integrate available evidence expert opinion, within outside the US medical...

10.1097/ta.0b013e318163c421 article EN Journal of Trauma and Acute Care Surgery 2008-03-01

To examine the outcomes of highly-active antiretroviral therapy (HAART) for individuals with free access to healthcare, we evaluated 2327 patients in a cohort study composed military personnel and beneficiaries HIV infection who initiated HAART from 1996 end 2007. Outcomes analyzed were virologic suppression (VS) failure (VF), CD4 count changes, AIDS death. VF was defined as never suppressing or having at least one rebound event. Multivariate (MV) analyses stratified by initiation year...

10.1186/1742-6405-7-14 article EN cc-by AIDS Research and Therapy 2010-01-01

Multidrug-resistant organism (MDRO) infections, including those secondary to Acinetobacter (ACB) and extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (Escherichia coli Klebsiella species) have complicated the care of combat-injured personnel during Operations Iraqi Freedom Enduring Freedom. Data suggest that source these bacterial infections includes nosocomial transmission in both deployed hospitals receiving military medical centers (MEDCENs). Admission screening for MDRO...

10.1097/ta.0b013e31822118fb article EN Journal of Trauma and Acute Care Surgery 2011-07-01

Abstract Background Intramuscular cabotegravir-rilpivirine (CAB-RPV) is a long-acting antiretroviral for the treatment of HIV which can be administered every 1-2 months. Registration trials demonstrated non-inferiority CAB-RPV versus oral therapy, but data on ‘real world’ performance sparse. In addition, these required virologic suppression (viral load (VL) < 50 copies/mL) with medications before transitioning to CAB-RPV. Small studies have reported success when was started in...

10.1093/ofid/ofae631.771 article EN cc-by Open Forum Infectious Diseases 2025-01-29
Coming Soon ...